# Cryogenic equipment for biotech Liquid-nitrogen storage tanks, controlled-rate freezers and cryogenic shipping systems that preserve cell/gene therapies, biospecimens and other biological materials at ultra-low temperature across manufacturing, storage and distribution, sold by dedicated cryogenic equipment and logistics providers. Source: https://en.bioecon.ru/technology/cryogenic-equipment-biotech/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: US FDA 21 CFR Part 210/211 + EU GMP Annex 1 for cryopreserved biological material storage and chain-of-custody | OECD: Bio-pharmaceuticals | Regulator: FDA (USA), EMA (EU), NMPA (China)] Cryogenic equipment maintains biological materials — cell and gene therapy products, cord blood, biospecimens, master and working cell banks — at temperatures cold enough to suspend biological activity, typically below -150°C using liquid nitrogen (LN2) vapor or liquid phase, or -80°C for ultra-low mechanical freezers. The category spans three distinct hardware classes: controlled-rate freezers that ramp temperature down at a programmed rate to protect cell viability during the freeze itself, isothermal or LN2-jacketed storage tanks that hold frozen product at stable temperature for long-duration storage, and cryogenic shipping systems (dry-vapor shippers) that maintain temperature during transport without the spill and pressure risks of liquid-phase LN2. A single cell or gene therapy product typically passes through all three equipment classes across its manufacturing-to-patient journey, with a validated chain-of-custody and temperature-excursion record required at every handoff. The key directions of cryogenic equipment for biotech are: 1. **Controlled-rate freezing:** programmable freezers that ramp temperature down at a validated rate (commonly 1°C/minute) to minimize ice-crystal damage and preserve cell viability during the freeze step itself. 2. **LN2-jacketed and isothermal storage tanks:** long-duration storage vessels that hold frozen product at stable cryogenic temperature, ranging from small lab tanks to high-capacity biorepository installations. 3. **Cryogenic shipping systems:** dry-vapor shippers that absorb liquid nitrogen into a porous matrix, maintaining cryogenic temperature during transport without free liquid phase, the standard for cell and gene therapy distribution logistics. 4. **Temperature-monitoring and chain-of-custody software:** connected sensors and tracking platforms that log temperature continuously and flag excursions across every handoff from manufacturing through patient administration. ### Sectoral value chain ``` [Cell/gene therapy product, biospecimen] ──> [Controlled-rate freezing] │ (validated freeze curve) │ ▼ [Patient/end-use site] <─── [Cryogenic shipping] <─── [LN2 storage tank / biorepository] ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **Controlled-rate freezing** | A programmable freezer ramps temperature down at a validated rate, protecting cell viability during the transition from liquid to frozen state. | **In:** unfrozen cell/gene therapy product or biospecimen. **Out:** frozen product at target storage temperature. | | **Cryogenic storage** | LN2-jacketed or isothermal tanks hold frozen product at stable cryogenic temperature for long-duration storage. | **In:** frozen product. **Out:** stored product, continuously temperature-logged. | | **Cryogenic shipping** | Dry-vapor shippers maintain cryogenic temperature during transport without free liquid-phase nitrogen. | **In:** stored frozen product. **Out:** product in transit, temperature-validated for the shipping duration. | | **Chain-of-custody tracking** | Connected temperature sensors and tracking software log continuous temperature data and flag excursions at every handoff. | **In:** product in transit or storage. **Out:** chain-of-custody record, excursion alerts. | | **Receipt and thaw** | The end-use site (clinic, manufacturing facility) receives and thaws the product under a validated protocol matched to its cryopreservation method. | **In:** received frozen product. **Out:** thawed, patient-ready or process-ready product. | | **GMP documentation** | Temperature records, chain-of-custody logs and excursion reports are compiled against a validated protocol for regulatory release. | **In:** monitoring data. **Out:** GMP-compliant storage and shipping record. | Cross-cutting technologies of the sector: - **Dry-vapor shipping technology:** a porous absorbent matrix holds liquid nitrogen in place, maintaining cryogenic vapor-phase temperature during transport without the pressure and spill risk of free liquid nitrogen. - **Multi-probe temperature monitoring:** controlled-rate freezers with multiple independent temperature probes validate that the freeze curve is uniform across the full sample load, not just at a single reference point. - **Connected chain-of-custody platforms:** cloud-linked temperature loggers provide continuous, auditable temperature records across every handoff from manufacturing through patient administration, a requirement increasingly specified for cell and gene therapy distribution. --- ## US The US hosts the category's leading cryogenic hardware manufacturers and the dominant cryogenic logistics provider serving the world's largest cell and gene therapy manufacturing and clinical distribution base. ### cryogenic storage hardware leadership, dry-vapor shipping logistics dominance - **Chart Industries (MVE brand):** the MVE 616 wide-neck cylindrical biological LN2 storage tank and the MVE HE series with CryoVerse Connect controller and automated fill/gas-bypass functions are distributed through biomedical equipment resellers, a widely specified biological LN2 storage standard. - **Custom Biogenic Systems:** manufactures both controlled-rate freezers with multi-probe monitoring and isothermal LN2-jacketed freezers, covering the freeze and long-duration storage steps of the pipeline from a single vendor. - **Cryoport:** the Cryoport Express and Cryomax cryogenic shipping systems are the reference dry-vapor shipping platforms for life-sciences supply chains, specifically positioned for cell and gene therapy distribution logistics. - **Worthington Industries (Taylor-Wharton brand):** the Taylor-Wharton LABS and VHC cryo storage tank lines are widely distributed through laboratory and biomedical equipment resellers, a long-established cryogenic tank brand. --- ## CN No China-headquartered cryogenic equipment maker cleared this screening round with confirmed, on-domain evidence; demand is driven by China's expanding cell and gene therapy manufacturing and biobanking base, currently served largely through global vendors' regional distribution networks. ### import- and distributor-served market, domestic cell/gene therapy build-out - **Global vendor distribution:** Chart Industries, Cryoport and other global cryogenic equipment and logistics providers maintain China distribution channels serving domestic cell and gene therapy manufacturing and biobanking. - **Domestic cell/gene therapy build-out:** China's growing cell and gene therapy manufacturing base is the main demand driver for cryogenic storage and shipping capacity, without a confirmed domestic cryogenic-equipment originator identified in this screen. - **Screening note:** one candidate China-headquartered cryogenic equipment maker was probed and did not return confirming, on-domain evidence this round — not asserted as absent, only as unconfirmed. --- ## EU No EU-headquartered vendor cleared this screening round; the category is dominated by US-headquartered cryogenic hardware and logistics providers whose global platforms (Chart/MVE, Cryoport, Taylor-Wharton) are also the reference standard specified across European cell and gene therapy manufacturing. ### global US brand specification, distributor-served European demand - **Global brand specification:** European cell and gene therapy manufacturers specify the same MVE, Custom Biogenic Systems, Cryoport and Taylor-Wharton equipment lines sold in the US market, distributed through European biomedical equipment channels. - **Screening note:** the region-specific search did not surface a distinct EU-headquartered cryogenic equipment originator with confirmed evidence in this round — not asserted as absent, only as unconfirmed. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **Chart Industries (MVE)** | 🇺🇸 USA | *MVE 616, MVE HE series with CryoVerse Connect* | Widely specified biological LN2 storage standard; automated fill/gas-bypass control | Commercial, public (NYSE: GTLS) | | **Cryoport** | 🇺🇸 USA | *Cryoport Express, Cryomax shipping systems* | Reference dry-vapor cryogenic shipping platform for cell/gene therapy logistics | Commercial, public (NASDAQ: CYRX) | | **Worthington Industries (Taylor-Wharton)** | 🇺🇸 USA | *Taylor-Wharton LABS, VHC cryo storage tanks* | Long-established, widely distributed cryogenic tank brand | Commercial, public (NYSE: WOR) | | **Custom Biogenic Systems** | 🇺🇸 USA | *Controlled-rate freezers, isothermal LN2 freezers* | Multi-probe freeze-curve monitoring; covers freeze and storage steps from one vendor | Commercial | --- ## Tech stack and innovations The stack layers programmable freeze-curve control, cryogenic storage engineering and dry-vapor shipping technology on a common temperature-monitoring and chain-of-custody backbone. 1. **Programmable controlled-rate freezing:** - Freezers ramp temperature down at a validated rate (commonly around 1°C/minute) to minimize ice-crystal formation and preserve cell viability during the freeze transition. - Multi-probe monitoring validates that the freeze curve is uniform across the full sample load rather than only at a single reference point, a requirement for GMP-documented cell therapy freezing. 2. **LN2-jacketed and automated-fill storage tanks:** - Isothermal, LN2-jacketed tank designs hold stored product at stable cryogenic temperature with minimized liquid-nitrogen consumption versus open liquid-phase storage. - Automated fill and gas-bypass controllers maintain tank LN2 level without manual intervention, reducing the risk of a temperature excursion from a missed refill. 3. **Dry-vapor cryogenic shipping:** - A porous absorbent matrix holds liquid nitrogen in place, maintaining cryogenic vapor-phase temperature during transport without the pressure and spill risk of free liquid-phase nitrogen. - Connected chain-of-custody platforms log continuous, auditable temperature data across every handoff from manufacturing through patient administration. --- ## Value chains and production pipelines ### Industrial pipeline of cryogenic biological material handling (21 CFR Part 210/211 / EU GMP Annex 1) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. Controlled-rate freezing │ ───> │ 2. Cryogenic storage │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Chain-of-custody tracking│ <─── │ 3. Cryogenic shipping │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. Receipt and thaw │ ───> │ 6. GMP documentation │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: Controlled-rate freezing A programmable freezer ramps the product's temperature down at a validated rate, protecting cell viability during the transition from liquid to frozen state. #### Stage 2: Cryogenic storage LN2-jacketed or isothermal tanks hold the frozen product at stable cryogenic temperature for long-duration storage, continuously temperature-logged. #### Stage 3: Cryogenic shipping A dry-vapor shipper maintains cryogenic temperature during transport without free liquid-phase nitrogen, validated for the shipping duration. #### Stage 4: Chain-of-custody tracking Connected temperature sensors and tracking software log continuous data and flag any excursion at every handoff from manufacturing through patient administration. #### Stage 5: Receipt and thaw The end-use site receives and thaws the product under a validated protocol matched to its cryopreservation method. #### Stage 6: GMP documentation Temperature records, chain-of-custody logs and excursion reports are compiled against a validated protocol under 21 CFR Part 210/211 and EU GMP Annex 1 for regulatory release. ---